Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by PoorOpinionon May 08, 2018 11:35am
108 Views
Post# 27997779

RE:Where is it best to find Taimed's monthly revenue

RE:Where is it best to find Taimed's monthly revenue
SPCEO1 wrote: Taimed's website rarely gets updated so it is not a good source. Does anyone know what the best source for these monthly revenue reports is? I believe they have to report on the 10th of each month. I was goign to search around for it but I suspect someone who followsw this board may already have the answer.


I'm hoping they get the monthly revenue page sorted out before the 10th but if not I always go to the MOPS page. I'm assuming this is the Taiwanese equivalent on SEDAR. Alot of the press reports (not the one's made up) are based on this info. But like SEDAR you cant bookmark directly to Taimeds page, it come up after a search of the database.

So I bookmark this page

https://mops.twse.com.tw/mops/web/index

Then search for taimed using their code number 4147, the search box appears top-middle for an iPAD. 4147 appears in a drop down menu, click this to go to Taimeds page. The news fillings appear in the second block of text. Atm there are three data 107/05/07 (107=2018), all. three are responses to press speculation about eps. Click on one of these and the report appears in a new window, you can copy and paste it into a translate program from there.

It might sound complicated, it isnt, and I think it represents the most reliable sourse of company info, like going to SEDAR. Maybe people know of reliable press websites. I cant distinguish between what might be bona fide media site and something more trashy.

Bullboard Posts